Burning mouth syndrome: A novel treatment

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509727-40-00

Enrollment

Registered

2024-04-22

Start date

2025-06-16

Completion date

Unknown

Last updated

2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burning mouth syndrome

Brief summary

Pain intensity [ Time Frame: will be assessed immediately before start of treatment as well as one, two and three weeks after treatment start ] Overall oral mucosa pain intensity. Will be assessed using the subscale "Characteristic pain intensity" (three numerical rating scales 0 - 10 assessing current pain. intensity as well as worst and average pain intensity during the last two weeks) in the Graded Chronic Pain Scale, Patient global impression of change (PGIC), Pain related disability

Detailed description

Somatosensory changes including taste changes, Jaw function limitation using JFLS-20, Stress using PSS-10, Pain catastrophizing using PCS

Interventions

DRUGCLONAZEPAM

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Pain intensity [ Time Frame: will be assessed immediately before start of treatment as well as one, two and three weeks after treatment start ] Overall oral mucosa pain intensity. Will be assessed using the subscale "Characteristic pain intensity" (three numerical rating scales 0 - 10 assessing current pain. intensity as well as worst and average pain intensity during the last two weeks) in the Graded Chronic Pain Scale, Patient global impression of change (PGIC), Pain related disability	—

Measure

Time frame

—

Secondary

Measure	Time frame
Somatosensory changes including taste changes, Jaw function limitation using JFLS-20, Stress using PSS-10, Pain catastrophizing using PCS	—

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026